Literature DB >> 18592161

Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.

Kazuhiro Shiizaki1, Ikuji Hatamura, Eiko Nakazawa, Manabu Ogura, Takahiro Masuda, Tadao Akizawa, Eiji Kusano.   

Abstract

The mechanisms explaining the clinical effects of direct maxacalcitol (OCT) injection into the hyperplastic parathyroid gland (PTG) in uremic patients with advanced secondary hyperparathyroidism (SHPT) were investigated by molecular and morphological examination. PTG of uremia-induced SHPT model rats were treated by a direct injection of OCT (DI-OCT) or vehicle (DI-vehicle). The changes in serum intact parathyroid hormone (intact-PTH) level, vitamin D and Ca-sensing receptor (VDR and CaSR, respectively) expression levels in PTG, and the calcium (Ca)-PTH response curve were examined; the induction of apoptosis in parathyroid cells (PTC) was also analyzed by the TUNEL method, DNA electrophoresis, and electron microscopic examination. Serum intact-PTH level following DI-OCT significantly decreased. Upregulation of both VDR and CaSR, a clear shift to the left downward in the Ca-PTH curve, and many apoptotic PTCs were observed in the DI-OCT-treated PTGs. However, these findings were not observed in the DI-vehicle-treated PTGs. Moreover, these effects were confirmed by the DI-OCT into one PTG and DI-vehicle alone into another PTG in the same rat. DI-OCT may introduce simultaneous VDR and CaSR upregulation and the regression of hyperplastic PTG, and these effects may provide a strategy for strongly suppressing PTH level in uremia-induced advanced SHPT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18592161     DOI: 10.1007/s00795-008-0399-6

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  43 in total

1.  Activation of vitamin D receptor by the Wilms' tumor gene product mediates apoptosis of renal cells.

Authors:  Kay-Dietrich Wagner; Nicole Wagner; Vikas P Sukhatme; Holger Scholz
Journal:  J Am Soc Nephrol       Date:  2001-06       Impact factor: 10.121

2.  PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.

Authors:  Mark D Danese; John Kim; Quan V Doan; Michelle Dylan; Robert Griffiths; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2006-01       Impact factor: 8.860

3.  Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer.

Authors:  Meral Guzey; Shinichi Kitada; John C Reed
Journal:  Mol Cancer Ther       Date:  2002-07       Impact factor: 6.261

4.  Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients.

Authors:  B S Levine; M Song
Journal:  J Am Soc Nephrol       Date:  1996-03       Impact factor: 10.121

5.  1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.

Authors:  Q Wang; W Yang; M S Uytingco; S Christakos; R Wieder
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

6.  Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cells.

Authors:  Kazuhiro Shiizaki; Naohiko Hayakawa; Ikuo Imazeki; Ikuji Hatamura; Tadashi Okada; Shigeo Negi; Toshifumi Sakaguchi; Takashi Shigematsu; Tadao Akizawa
Journal:  Nephrol Dial Transplant       Date:  2007-01-18       Impact factor: 5.992

7.  Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats.

Authors:  Kazuhiro Shiizaki; Ikuji Hatamura; Shigeo Negi; Toshifumi Sakaguchi; Fumie Saji; Ikuo Imazeki; Eiji Kusano; Takashi Shigematsu; Tadao Akizawa
Journal:  Nephrol Dial Transplant       Date:  2007-12-21       Impact factor: 5.992

8.  Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD.

Authors:  L D Quarles; D A Yohay; B A Carroll; C E Spritzer; S A Minda; D Bartholomay; B A Lobaugh
Journal:  Kidney Int       Date:  1994-06       Impact factor: 10.612

9.  Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.

Authors:  Eduardo Slatopolsky; Mario Cozzolino; Yan Lu; Jane Finch; Andriana Dusso; Marc Staniforth; Yoo Wein; Jee Webster
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

10.  The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.

Authors:  A J Brown; C R Ritter; J L Finch; J Morrissey; K J Martin; E Murayama; Y Nishii; E Slatopolsky
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.